The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy
- PMID: 20148083
- PMCID: PMC2817866
- DOI: 10.1155/2009/431980
The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy
Abstract
We demonstrated that inhibition of neutral endopeptidase (NEP), a protease that degrades vaso- and neuroactive peptides, improves vascular and neural function in diabetic animal models. In this study we explored the role of NEP in neuropathy related to either insulin-deficient diabetes or diet-induced obesity using NEP deficient (-/-) mice. Initial studies showed that streptozotocin, in the absence of subsequent hyperglycemia, did not induce nerve conduction slowing or paw thermal hypoalgesia. Glucose disposal was impaired in both C57Bl/6 and NEP -/- mice fed a high fat diet. Thermal hypoalgesia and nerve conduction slowing were present in both streptozotocin-diabetic and high fat fed C57Bl/6 mice but not in NEP -/- mice exposed to either streptozotocin-induced diabetes or a high fat diet. These studies suggest that streptozotocin does not induce neurotoxicity in mice and that NEP plays a role in regulating nerve function in insulin-deficient diabetes and diet-induced obesity.
Figures



Similar articles
-
Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.Neuropharmacology. 2011 Feb-Mar;60(2-3):259-66. doi: 10.1016/j.neuropharm.2010.09.008. Epub 2010 Sep 16. Neuropharmacology. 2011. PMID: 20849865 Free PMC article.
-
Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.Eur J Pharmacol. 2012 Feb 29;677(1-3):180-7. doi: 10.1016/j.ejphar.2011.12.003. Epub 2011 Dec 14. Eur J Pharmacol. 2012. PMID: 22198047 Free PMC article.
-
Effect of Inhibition or Deletion of Neutral Endopeptidase on Neuropathic Endpoints in High Fat Fed/Low Dose Streptozotocin-Treated Mice.J Neuropathol Exp Neurol. 2016 Nov 1;75(11):1072-1080. doi: 10.1093/jnen/nlw083. J Neuropathol Exp Neurol. 2016. PMID: 27634964 Free PMC article.
-
Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.Eur J Pharmacol. 2011 Jan 15;650(2-3):556-62. doi: 10.1016/j.ejphar.2010.10.047. Epub 2010 Oct 30. Eur J Pharmacol. 2011. PMID: 21040718 Free PMC article.
-
Alternatives to the Streptozotocin-Diabetic Rodent.Int Rev Neurobiol. 2016;127:89-112. doi: 10.1016/bs.irn.2016.03.002. Epub 2016 Mar 28. Int Rev Neurobiol. 2016. PMID: 27133146 Free PMC article. Review.
Cited by
-
Peripheral Neuropathy in Mouse Models of Diabetes.Curr Protoc Mouse Biol. 2016 Sep 1;6(3):223-255. doi: 10.1002/cpmo.11. Curr Protoc Mouse Biol. 2016. PMID: 27584552 Free PMC article. Review.
-
Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189.Diabetes. 2019 Nov;68(11):2143-2154. doi: 10.2337/db19-0271. Epub 2019 Sep 6. Diabetes. 2019. PMID: 31492662 Free PMC article.
-
An overview of animal models of pain: disease models and outcome measures.J Pain. 2013 Nov;14(11):1255-69. doi: 10.1016/j.jpain.2013.06.008. Epub 2013 Sep 12. J Pain. 2013. PMID: 24035349 Free PMC article. Review.
-
Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications.Exp Diabetes Res. 2011;2011:810469. doi: 10.1155/2011/810469. Epub 2011 Jul 21. Exp Diabetes Res. 2011. PMID: 21822422 Free PMC article.
-
Insulin Treatment Attenuates Small Nerve Fiber Damage in Rat Model of Type 2 Diabetes.J Diabetes Res. 2020 Aug 2;2020:9626398. doi: 10.1155/2020/9626398. eCollection 2020. J Diabetes Res. 2020. PMID: 32832565 Free PMC article.
References
-
- Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–962. - PubMed
-
- Ziegler D. Treatment of diabetic polyneuropathy update 2006. Annals of the New York Academy of Sciences. 2006;1084:250–266. - PubMed
-
- Tavakoli M, Malik RA. Management of painful diabetic neuropathy. Expert Opinion on Pharmacotherapy. 2008;9(17):2969–2978. - PubMed
-
- Singleton JR, Smith AG. Therapy insight: neurological complications of prediabetes. Nature Clinical Practice Neurology. 2006;2(5):276–282. - PubMed
-
- Smith AG, Singleton JR. Impaired glucose tolerance and neuropathy. Neurologist. 2008;14(1):23–29. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical